<DOC>
	<DOC>NCT02381977</DOC>
	<brief_summary>PANGEA is an international prospective point prevalence study to describe the epidemiology, interventions, and outcomes in children with acute critical brain disease.</brief_summary>
	<brief_title>Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment</brief_title>
	<detailed_description />
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Hydrocephalus</mesh_term>
	<mesh_term>Status Epilepticus</mesh_term>
	<mesh_term>Spinal Cord Diseases</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<criteria>1. Children aged 7 days to 17 years inclusively and admitted to an ICU (ICU can be classified as general, cardiac, trauma, etc). 2. Children with acute or acute on chronic neurologic disease that occurred just prior to hospital admission or occurred during the hospital admission. 3. Acute neurologic disease is secondary to TBI, stroke, brain mass, hydrocephalus, cardiac arrest, status epilepticus, CNS infection/inflammation, or spinal cord injury. 1. Children with acute perinatal neurologic disease. 2. Children with isolated chronic brain injury and no acute neurologic disease.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>